logo
Select company
Select metric
$ -68.05MNet Cash Flow - Investing
VS
Market
40
Sector
19
Industry
11
History
33
$ 10.05Close
$ 3.7 - $ 11.11 52-Week Range
Ticker Information

Ticker

GLUE

Company Name

MONTE ROSA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

MONTE ROSA THERAPEUTICS INC - Net Cash Flow - Investing Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

GLUE - CF - Investing Historical data
DateNet Cash Flow - Investing
6/30/2025$ -68.05M
3/31/2025$ -154.53M
12/31/2024$ -44.45M
9/30/2024$ 741K
6/30/2024$ -1.38M
3/31/2024$ 78.33M
12/31/2023$ 88.8M
9/30/2023$ 20.57M
6/30/2023$ 14.43M
3/31/2023$ -18.37M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • MONTE ROSA THERAPEUTICS INC's latest trailing twelve months (TTM) CF - Investing stands at $ -3.39M.
  • Over the past 5 years, MONTE ROSA THERAPEUTICS INC's average CF - Investing has been $ -54.5M.
  • The median CF - Investing for MONTE ROSA THERAPEUTICS INC during this period was $ -14.01M
  • MONTE ROSA THERAPEUTICS INC reached its highest CF - Investing over the past 5 years at $ 88.8M.
  • The lowest CF - Investing recorded by MONTE ROSA THERAPEUTICS INC in the same timeframe $ -219.22M

MONTE ROSA THERAPEUTICS INC's CF - Investing vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Investing Benchmarks
CompanyCF - Investing
VNDA : VANDA PHARMACEUTICALS INC $ 44.68MHRTX : HERON THERAPEUTICS INC $ 25MARCT : ARCTURUS THERAPEUTICS HOLDINGS INC $ -217KCTMX : CYTOMX THERAPEUTICS INC $ -12.46MRGNX : REGENXBIO INC $ -5.16MMGNX : MACROGENICS INC $ 49.33MTRDA : ENTRADA THERAPEUTICS INC $ 9.02MPBYI : PUMA BIOTECHNOLOGY INC $ -11.78MCDXS : CODEXIS INC $ 10.07MSCPH : SCPHARMACEUTICALS INC $ -21K

Definition of Net Cash Flow - Investing

[Cash Flow Statement] The amount of cash inflow (outflow) from investing activities. Investing actives include disposal (expenditure) of capital assets [CapEx], sale (purchase) of business [NCFBus] and of investments [NCFInv].

GLUE - Net Cash Flow - Investing, Last 5 years

$ -219.22M

Minimum

Dec 31, 2022

$ 88.8M

Maximum

Dec 31, 2023

$ -54.5M

Average

$ -14.01M

Median

CF - Investing Benchmark Analysis

The chart above depicts the distribution of CF - Investing for companies in the Total Stock Market. The average CF - Investing of the companies is $ -35.29M with a standard deviation of $ 83.34M.
The following table provides additional summary stats:
CF - Investing in the Market:
filtered constituents3.17K
min$ -292.23M
max$ 241M
average$ -35.29M
median$ -6.38M
std$ 83.34M